TY - JOUR
T1 - Do Inflammatory Cytokines Affect Patient Outcomes After ACDF?
AU - Karamian, Brian A.
AU - Levy, Hannah A.
AU - Boere, Payton
AU - Yalla, Goutham R.
AU - Canseco, Jose A.
AU - Chang, Michael
AU - Divi, Srikanth N.
AU - Fang, Taolin
AU - Millhouse, Paul W.
AU - Lendner, Mayan
AU - Hilibrand, Alan S.
AU - Vaccaro, Alexander R.
AU - Kepler, Christopher K.
AU - Markova, Dessislava Z.
AU - Schroeder, Gregory D.
N1 - Publisher Copyright:
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Study Design: Prospective cohort study. Objective: The aim was to determine the relationship between serum inflammatory mediators, preoperative cervical spine disease severity, and clinical outcomes after anterior cervical discectomy and fusion (ACDF). Summary of Background Data: Given the role of the inflammatory cascade in spinal degenerative disease, it has been hypothesized that inflammatory markers may serve as a predictor of patient outcomes after surgery. Materials and Methods: All patients over age 18 who underwent ACDF for cervical spondylosis with associated radiculopathy and/ or myelopathy between 2015 and 2017 from a single institution were prospectively recruited. Preoperative serum inflammatory markers including interleukin (IL)-6, IL-8, tumor necrosis factor-α, high-mobility group box-1 (HMGB1), and white blood cells were measured and correlated to patient demographics, surgical characteristics, duration of symptoms, previous opioid use, and preoperative and 1-year postoperative patient-reported outcomes measures (PROMs) including the neck disability index (NDI), visual analog scale neck pain, visual analog scale arm pain, and Physical and Mental Component Scores of the Short Form-12 (PCS and MCS, respectively) using spearman’s rho coefficient. Results: A total of 77 patients were enrolled with follow-up PROMs available for 62% (n = 48) of patients at a minimum of 1-year after ACDF. The absolute concentrations of IL-6 and tumor necrosis factor-α were found to be weakly correlated with one another (ρ = 0.479). Preoperative symptoms lasting <1-year were weakly correlated with elevation in HMGB1 (ρ = 0.421). All other patient demographics exhibited negligible correlation with the preoperative inflammatory markers. Lower preoperative PCS (ρ = 0.355) and higher preoperative NDI (ρ = 0.336) were weakly correlated with elevated HMGB1. Lower MCS (ρ = 0.395) and higher NDI (ρ = 0.317) preoperatively were weakly correlated with elevated white blood cells. Postoperative improvement in MCS (ρ = 0.306) and MCS recovery ratio (ρ = 0.321) exhibited a weakly positive correlation with IL-6. Conclusion: Preoperative cytokine levels demonstrated minimal correlation with preoperative symptoms or clinical improvement, suggesting that profiling of patient cytokines has limited utility in predicting outcomes after ACDF. Level of Evidence: Level III. (WBCs)] and preoperative cervical spine disease severity as well as functional improvement after ACDF.
AB - Study Design: Prospective cohort study. Objective: The aim was to determine the relationship between serum inflammatory mediators, preoperative cervical spine disease severity, and clinical outcomes after anterior cervical discectomy and fusion (ACDF). Summary of Background Data: Given the role of the inflammatory cascade in spinal degenerative disease, it has been hypothesized that inflammatory markers may serve as a predictor of patient outcomes after surgery. Materials and Methods: All patients over age 18 who underwent ACDF for cervical spondylosis with associated radiculopathy and/ or myelopathy between 2015 and 2017 from a single institution were prospectively recruited. Preoperative serum inflammatory markers including interleukin (IL)-6, IL-8, tumor necrosis factor-α, high-mobility group box-1 (HMGB1), and white blood cells were measured and correlated to patient demographics, surgical characteristics, duration of symptoms, previous opioid use, and preoperative and 1-year postoperative patient-reported outcomes measures (PROMs) including the neck disability index (NDI), visual analog scale neck pain, visual analog scale arm pain, and Physical and Mental Component Scores of the Short Form-12 (PCS and MCS, respectively) using spearman’s rho coefficient. Results: A total of 77 patients were enrolled with follow-up PROMs available for 62% (n = 48) of patients at a minimum of 1-year after ACDF. The absolute concentrations of IL-6 and tumor necrosis factor-α were found to be weakly correlated with one another (ρ = 0.479). Preoperative symptoms lasting <1-year were weakly correlated with elevation in HMGB1 (ρ = 0.421). All other patient demographics exhibited negligible correlation with the preoperative inflammatory markers. Lower preoperative PCS (ρ = 0.355) and higher preoperative NDI (ρ = 0.336) were weakly correlated with elevated HMGB1. Lower MCS (ρ = 0.395) and higher NDI (ρ = 0.317) preoperatively were weakly correlated with elevated white blood cells. Postoperative improvement in MCS (ρ = 0.306) and MCS recovery ratio (ρ = 0.321) exhibited a weakly positive correlation with IL-6. Conclusion: Preoperative cytokine levels demonstrated minimal correlation with preoperative symptoms or clinical improvement, suggesting that profiling of patient cytokines has limited utility in predicting outcomes after ACDF. Level of Evidence: Level III. (WBCs)] and preoperative cervical spine disease severity as well as functional improvement after ACDF.
KW - anterior cervical discectomy and fusion
KW - clinical outcomes
KW - inflammatory markers
KW - patient-reported outcome measures
KW - serum cytokines
UR - http://www.scopus.com/inward/record.url?scp=85129465761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129465761&partnerID=8YFLogxK
U2 - 10.1097/BSD.0000000000001318
DO - 10.1097/BSD.0000000000001318
M3 - Article
C2 - 35351842
AN - SCOPUS:85129465761
SN - 2380-0186
VL - 35
SP - 137
EP - 143
JO - Clinical spine surgery
JF - Clinical spine surgery
IS - 4
ER -